{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T23:37:08Z","timestamp":1767829028633,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T00:00:00Z","timestamp":1500336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T00:00:00Z","timestamp":1500336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Phenotype transition of peritoneum is an early mechanism of peritoneal fibrosis. Metformin, 5\u2032-adenosine monophosphate-activated protein kinase (AMPK) activator, has recently received a new attention due to its preventive effect on organ fibrosis and cancer metastasis by inhibiting epithelial-to-mesenchymal transition (EMT). We investigated the effect of metformin on EMT of human peritoneal mesothelial cells (HPMC) and animal model of peritoneal dialysis (PD). TGF-\u03b21-induced EMT in HPMC was ameliorated by metformin. Metformin alleviated NAPDH oxidase- and mitochondria-mediated ROS production with an increase in superoxide dismutase (SOD) activity and SOD2 expression. Metformin inhibited the activation of Smad2\/3 and MAPK, GSK-3\u03b2 phosphorylation, nuclear translocalization of \u03b2-catenin and Snail in HPMCs. Effect of metformin on TGF-\u03b21-induced EMT was ameliorated by either AMPK inhibitor or AMPK gene silencing. Another AMPK agonist, 5-amino-1-\u03b2-D-ribofuranosyl-imidazole-4-carboxamide partially blocked TGF-\u03b21-induced EMT. In animal model of PD, intraperitoneal metformin decreased the peritoneal thickness and EMT with an increase in ratio of reduced to oxidized glutathione and the expression of SOD whereas it decreased the expression of nitrotyrosine and 8-hydroxy-2\u2032-deoxyguanosine. Therefore, a modulation of AMPK in peritoneum can be a novel tool to prevent peritoneal fibrosis by providing a favorable oxidant\/anti-oxidant milieu in peritoneal cavity and ameliorating phenotype transition of peritoneal mesothelial cells.<\/jats:p>","DOI":"10.1038\/s41598-017-05836-6","type":"journal-article","created":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T11:22:37Z","timestamp":1499858557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Metformin ameliorates the Phenotype Transition of Peritoneal Mesothelial Cells and Peritoneal Fibrosis via a modulation of Oxidative Stress"],"prefix":"10.1038","volume":"7","author":[{"given":"Hyun-Soo","family":"Shin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7183-2336","authenticated-orcid":false,"given":"Jiyeon","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dal-Ah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Sun","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye-Myung","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun-Hee","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Lim","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eok-Soo","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duk-Hee","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,18]]},"reference":[{"key":"5836_CR1","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nrneph.2013.99","volume":"9","author":"RT Krediet","year":"2013","unstructured":"Krediet, R. T. & Struijk, D. G. Peritoneal changes in patients on long-term peritoneal dialysis. Nat Rev Nephrol \n                           9, 419\u2013429 (2013).","journal-title":"Nat Rev Nephrol"},{"key":"5836_CR2","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1681\/ASN.V132470","volume":"13","author":"JD Williams","year":"2002","unstructured":"Williams, J. D. et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol \n                           13, 470\u2013479 (2002).","journal-title":"J Am Soc Nephrol"},{"key":"5836_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa020809","volume":"348","author":"M Yanez-Mo","year":"2003","unstructured":"Yanez-Mo, M. et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med \n                           348, 403\u2013413 (2003).","journal-title":"N Engl J Med"},{"key":"5836_CR4","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1681\/ASN.2006111292","volume":"18","author":"LS Aroeira","year":"2007","unstructured":"Aroeira, L. S. et al. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol \n                           18, 2004\u20132013 (2007).","journal-title":"J Am Soc Nephrol"},{"key":"5836_CR5","doi-asserted-by":"crossref","unstructured":"Selgas, R. et al. Epithelial-to-mesenchymal transition of the mesothelial cell\u2013its role in the response of the peritoneum to dialysis. Nephrol Dial Transplant \n                           21 Suppl 2 (2006).","DOI":"10.1093\/ndt\/gfl183"},{"key":"5836_CR6","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1681\/ASN.2008040424","volume":"20","author":"MA Yu","year":"2009","unstructured":"Yu, M. A. et al. HGF and BMP-7 ameliorate high glucose-induced epithelial-to-mesenchymal transition of peritoneal mesothelium. J Am Soc Nephrol \n                           20, 567\u2013581 (2009).","journal-title":"J Am Soc Nephrol"},{"key":"5836_CR7","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/labinvest.2015.91","volume":"95","author":"HS Shin","year":"2015","unstructured":"Shin, H. S., Ryu, E. S., Oh, E. S. & Kang, D. H. Endoplasmic reticulum stress as a novel target to ameliorate epithelial-to-mesenchymal transition and apoptosis of human peritoneal mesothelial cells. Lab Invest \n                           95, 1157\u20131173 (2015).","journal-title":"Lab Invest"},{"key":"5836_CR8","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1172\/JCI44595","volume":"121","author":"W Kriz","year":"2011","unstructured":"Kriz, W., Kaissling, B. & Le Hir, M. Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? J Clin Invest \n                           121, 468\u2013474 (2011).","journal-title":"J Clin Invest"},{"key":"5836_CR9","doi-asserted-by":"publisher","unstructured":"Taura, K., Iwaisako, K., Hatano, E. & Uemoto, S. Controversies over the Epithelial-to-Mesenchymal Transition in Liver Fibrosis. J Clin Med \n                           5, doi:10.3390\/jcm5010009 (2016).","DOI":"10.3390\/jcm5010009"},{"key":"5836_CR10","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/nm.3414","volume":"19","author":"RJ Shaw","year":"2013","unstructured":"Shaw, R. J. Metformin trims fats to restore insulin sensitivity. Nat Med \n                           19, 1570\u20131572 (2013).","journal-title":"Nat Med"},{"key":"5836_CR11","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.4161\/cc.9.18.13131","volume":"9","author":"A Vazquez-Martin","year":"2010","unstructured":"Vazquez-Martin, A. et al. Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status. Cell Cycle \n                           9, 3807\u20133814 (2010).","journal-title":"Cell Cycle"},{"key":"5836_CR12","doi-asserted-by":"crossref","first-page":"43605","DOI":"10.18632\/oncotarget.6186","volume":"6","author":"L Li","year":"2015","unstructured":"Li, L. et al. Metformin attenuates gefitinib-induced exacerbation of pulmonary fibrosis by inhibition of TGF-beta signaling pathway. Oncotarget \n                           6, 43605\u201343619 (2015).","journal-title":"Oncotarget"},{"key":"5836_CR13","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1634\/theoncologist.2013-0111","volume":"18","author":"M Yin","year":"2013","unstructured":"Yin, M., Zhou, J., Gorak, E. J. & Quddus, F. Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis. Oncologist \n                           18, 1248\u20131255 (2013).","journal-title":"Oncologist"},{"key":"5836_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.mce.2015.06.006","volume":"412","author":"RC Cavaglieri","year":"2015","unstructured":"Cavaglieri, R. C., Day, R. T., Feliers, D. & Abboud, H. E. Metformin prevents renal interstitial fibrosis in mice with unilateral ureteral obstruction. Mol Cell Endocrinol \n                           412, 116\u2013122 (2015).","journal-title":"Mol Cell Endocrinol"},{"key":"5836_CR15","doi-asserted-by":"publisher","first-page":"F686","DOI":"10.1152\/ajprenal.00148.2012","volume":"304","author":"JH Lee","year":"2013","unstructured":"Lee, J. H. et al. AMP-activated protein kinase inhibits TGF-beta-, angiotensin II-, aldosterone-, high glucose-, and albumin-induced epithelial-mesenchymal transition. Am J Physiol Renal Physiol \n                           304, F686\u2013697 (2013).","journal-title":"Am J Physiol Renal Physiol"},{"key":"5836_CR16","doi-asserted-by":"publisher","first-page":"8249","DOI":"10.1007\/s13277-015-4639-9","volume":"37","author":"NS Li","year":"2016","unstructured":"Li, N. S. et al. LKB1\/AMPK inhibits TGF-beta1 production and the TGF-beta signaling pathway in breast cancer cells. Tumour Biol \n                           37, 8249\u20138258 (2016).","journal-title":"Tumour Biol"},{"key":"5836_CR17","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/jcp.22824","volume":"227","author":"JY Lim","year":"2012","unstructured":"Lim, J. Y., Oh, M. A., Kim, W. H., Sohn, H. Y. & Park, S. I. AMP-activated protein kinase inhibits TGF-beta-induced fibrogenic responses of hepatic stellate cells by targeting transcriptional coactivator p300. J Cell Physiol \n                           227, 1081\u20131089 (2012).","journal-title":"J Cell Physiol"},{"key":"5836_CR18","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/cvr\/cvq066","volume":"87","author":"H Xiao","year":"2010","unstructured":"Xiao, H. et al. Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway. Cardiovasc Res \n                           87, 504\u2013513 (2010).","journal-title":"Cardiovasc Res"},{"key":"5836_CR19","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1159\/000363006","volume":"34","author":"A Lan","year":"2014","unstructured":"Lan, A., Qi, Y. & Du, J. Akt2 mediates TGF-beta1-induced epithelial to mesenchymal transition by deactivating GSK3beta\/snail signaling pathway in renal tubular epithelial cells. Cell Physiol Biochem \n                           34, 368\u2013382 (2014).","journal-title":"Cell Physiol Biochem"},{"key":"5836_CR20","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.phrs.2008.02.001","volume":"57","author":"F Caraci","year":"2008","unstructured":"Caraci, F. et al. TGF-beta1 targets the GSK-3beta\/beta-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts. Pharmacol Res \n                           57, 274\u2013282 (2008).","journal-title":"Pharmacol Res"},{"key":"5836_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12885-015-1119-y","volume":"15","author":"Q Ji","year":"2015","unstructured":"Ji, Q. et al. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-beta1\/Smads signaling pathway mediated Snail\/E-cadherin expression. BMC Cancer \n                           15, 97 (2015).","journal-title":"BMC Cancer"},{"key":"5836_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3747\/pdi.2014.00188","volume":"35","author":"Y Liu","year":"2015","unstructured":"Liu, Y. et al. Transition of mesothelial cell to fibroblast in peritoneal dialysis: EMT, stem cell or bystander? Perit Dial Int \n                           35, 14\u201325 (2015).","journal-title":"Perit Dial Int"},{"key":"5836_CR23","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/labinvest.2012.166","volume":"93","author":"YH Jang","year":"2013","unstructured":"Jang, Y. H. et al. Effects of dexamethasone on the TGF-beta1-induced epithelial-to-mesenchymal transition in human peritoneal mesothelial cells. Lab Invest \n                           93, 194\u2013206 (2013).","journal-title":"Lab Invest"},{"key":"5836_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.krcp.2015.03.005","volume":"34","author":"M Yu","year":"2015","unstructured":"Yu, M. et al. Effect of aldosterone on epithelial-to-mesenchymal transition of human peritoneal mesothelial cells. Kidney Res Clin Pract \n                           34, 83\u201392 (2015).","journal-title":"Kidney Res Clin Pract"},{"key":"5836_CR25","doi-asserted-by":"publisher","first-page":"e61165","DOI":"10.1371\/journal.pone.0061165","volume":"8","author":"J Loureiro","year":"2013","unstructured":"Loureiro, J. et al. Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis. PLoS One \n                           8, e61165 (2013).","journal-title":"PLoS One"},{"key":"5836_CR26","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/1471-2407-9-325","volume":"9","author":"CP Prasad","year":"2009","unstructured":"Prasad, C. P. et al. Expression analysis of E-cadherin, Slug and GSK3beta in invasive ductal carcinoma of breast. BMC Cancer \n                           9, 325 (2009).","journal-title":"BMC Cancer"},{"key":"5836_CR27","doi-asserted-by":"publisher","first-page":"e95884","DOI":"10.1371\/journal.pone.0095884","volume":"9","author":"Z Zhao","year":"2014","unstructured":"Zhao, Z. et al. Metformin inhibits the IL-6-induced epithelial-mesenchymal transition and lung adenocarcinoma growth and metastasis. PLoS One \n                           9, e95884 (2014).","journal-title":"PLoS One"},{"key":"5836_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11010-013-1845-x","volume":"386","author":"C Qu","year":"2014","unstructured":"Qu, C. et al. Metformin reverses multidrug resistance and epithelial-mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells. Mol Cell Biochem \n                           386, 63\u201371 (2014).","journal-title":"Mol Cell Biochem"},{"key":"5836_CR29","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1158\/1078-0432.CCR-13-2613","volume":"20","author":"L Li","year":"2014","unstructured":"Li, L. et al. Metformin sensitizes EGFR-TKI-resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversal. Clin Cancer Res \n                           20, 2714\u20132726 (2014).","journal-title":"Clin Cancer Res"},{"key":"5836_CR30","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s13287-015-0249-0","volume":"6","author":"R Zhang","year":"2015","unstructured":"Zhang, R. et al. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells. Stem Cell Res Ther \n                           6, 262 (2015).","journal-title":"Stem Cell Res Ther"},{"key":"5836_CR31","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.bbrc.2014.08.154","volume":"452","author":"J Zhang","year":"2014","unstructured":"Zhang, J. et al. Metformin inhibits epithelial-mesenchymal transition in prostate cancer cells: involvement of the tumor suppressor miR30a and its target gene SOX4. Biochem Biophys Res Commun \n                           452, 746\u2013752 (2014).","journal-title":"Biochem Biophys Res Commun"},{"key":"5836_CR32","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/j.1523-1755.2004.00491.x","volume":"65","author":"HB Lee","year":"2004","unstructured":"Lee, H. B., Yu, M. R., Song, J. S. & Ha, H. Reactive oxygen species amplify protein kinase C signaling in high glucose-induced fibronectin expression by human peritoneal mesothelial cells. Kidney Int \n                           65, 1170\u20131179 (2004).","journal-title":"Kidney Int"},{"key":"5836_CR33","doi-asserted-by":"publisher","first-page":"G100","DOI":"10.1152\/ajpgi.00329.2014","volume":"309","author":"M Cahova","year":"2015","unstructured":"Cahova, M. et al. Metformin prevents ischemia reperfusion-induced oxidative stress in the fatty liver by attenuation of reactive oxygen species formation. Am J Physiol Gastrointest Liver Physiol \n                           309, G100\u2013111 (2015).","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"5836_CR34","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/ki.2010.11","volume":"77","author":"AI Morales","year":"2010","unstructured":"Morales, A. I. et al. Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway. Kidney Int \n                           77, 861\u2013869, doi:10.1038\/ki.2010.11 (2010).","journal-title":"Kidney Int"},{"key":"5836_CR35","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.2337\/db13-0039","volume":"62","author":"MP Bhatt","year":"2013","unstructured":"Bhatt, M. P., Lim, Y. C., Kim, Y. M. & Ha, K. S. C-peptide activates AMPKalpha and prevents ROS-mediated mitochondrial fission and endothelial apoptosis in diabetes. Diabetes \n                           62, 3851\u20133862 (2013).","journal-title":"Diabetes"},{"key":"5836_CR36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.bbrc.2015.08.009","volume":"465","author":"L Cai","year":"2015","unstructured":"Cai, L. et al. AMPK dependent protective effects of metformin on tumor necrosis factor-induced apoptotic liver injury. Biochem Biophys Res Commun \n                           465, 381\u2013386 (2015).","journal-title":"Biochem Biophys Res Commun"},{"key":"5836_CR37","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1152\/japplphysiol.00383.2007","volume":"103","author":"DA Liem","year":"2007","unstructured":"Liem, D. A., Honda, H. M., Zhang, J., Woo, D. & Ping, P. Past and present course of cardioprotection against ischemia-reperfusion injury. Journal of applied physiology \n                           103, 2129\u20132136 (2007).","journal-title":"Journal of applied physiology"},{"key":"5836_CR38","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.2337\/diabetes.51.8.2420","volume":"51","author":"SA Hawley","year":"2002","unstructured":"Hawley, S. A., Gadalla, A. E., Olsen, G. S. & Hardie, D. G. The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes \n                           51, 2420\u20132425 (2002).","journal-title":"Diabetes"},{"key":"5836_CR39","doi-asserted-by":"publisher","first-page":"e0135858","DOI":"10.1371\/journal.pone.0135858","volume":"10","author":"SY Lee","year":"2015","unstructured":"Lee, S. Y. et al. Metformin Ameliorates Inflammatory Bowel Disease by Suppression of the STAT3 Signaling Pathway and Regulation of the between Th17\/Treg Balance. PLoS One \n                           10, e0135858 (2015).","journal-title":"PLoS One"},{"key":"5836_CR40","first-page":"1202","volume":"15","author":"H Soraya","year":"2012","unstructured":"Soraya, H. et al. Anti-angiogenic Effects of Metformin, an AMPK Activator, on Human Umbilical Vein Endothelial Cells and on Granulation Tissue in Rat. Iran J Basic Med Sci \n                           15, 1202\u20131209 (2012).","journal-title":"Iran J Basic Med Sci"},{"key":"5836_CR41","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/j.ajpath.2015.04.014","volume":"185","author":"S Thakur","year":"2015","unstructured":"Thakur, S. et al. Activation of AMP-activated protein kinase prevents TGF-beta1-induced epithelial-mesenchymal transition and myofibroblast activation. Am J Pathol \n                           185, 2168\u20132180 (2015).","journal-title":"Am J Pathol"},{"key":"5836_CR42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.metabol.2015.10.014","volume":"65","author":"R DeFronzo","year":"2016","unstructured":"DeFronzo, R., Fleming, G. A., Chen, K. & Bicsak, T. A. Metformin-associated lactic acidosis: Current perspectives on causes and risk. Metabolism \n                           65, 20\u201329 (2016).","journal-title":"Metabolism"},{"key":"5836_CR43","doi-asserted-by":"crossref","unstructured":"Salpeter, S. R., Greyber, E., Pasternak, G. A. & Salpeter, E. E. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev CD002967 (2010).","DOI":"10.1002\/14651858.CD002967.pub4"},{"key":"5836_CR44","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3747\/pdi.2013.00048","volume":"34","author":"AK Al-Hwiesh","year":"2014","unstructured":"Al-Hwiesh, A. K. et al. Metformin in peritoneal dialysis: a pilot experience. Perit Dial Int \n                           34, 368\u2013375 (2014).","journal-title":"Perit Dial Int"},{"key":"5836_CR45","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2165\/11534750-000000000-00000","volume":"50","author":"GG Graham","year":"2011","unstructured":"Graham, G. G. et al. Clinical pharmacokinetics of metformin. Clinical pharmacokinetics \n                           50, 81\u201398 (2011).","journal-title":"Clinical pharmacokinetics"},{"key":"5836_CR46","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/cr.2011.127","volume":"22","author":"J Gwak","year":"2012","unstructured":"Gwak, J. et al. Small molecule-based disruption of the Axin\/beta-catenin protein complex regulates mesenchymal stem cell differentiation. Cell research \n                           22, 237\u2013247 (2012).","journal-title":"Cell research"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05836-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05836-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05836-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T06:49:51Z","timestamp":1671778191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05836-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,18]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["5836"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-05836-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,18]]},"assertion":[{"value":"14 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5690"}}